Related Experiment Video

Updated: Aug 3, 2026

A Protocol for Analyzing Hepatitis C Virus Replication
13:04

A Protocol for Analyzing Hepatitis C Virus Replication

Published on: June 26, 2014

Hepatitis C infection in plasmapheresis donors: an overlooked risk factor for transmission?

C M Smyth1, D S Manning, M F Byrne

  • 1Department of Clinical Pharmacology and Gastroenterology, Beaumont Hospital and Royal College of Surgeons of Ireland, Dublin, Ireland.

European Journal of Gastroenterology & Hepatology
|August 13, 2002
PubMed

Insights

Hepatitis C virus (HCV) infection can occur through plasmapheresis donation. This overlooked transmission route poses risks to both donors and recipients, highlighting a need for improved safety protocols in blood donation centers.

Area of Science:

  • Hepatology
  • Infectious Diseases
  • Public Health

Background:

  • Hepatitis C virus (HCV) is a major global cause of chronic liver disease.
  • Identifiable transmission routes for HCV are not always found.
  • Plasmapheresis donation centers may harbor HCV-positive donors, posing a risk.

Observation:

  • Two patients contracted Hepatitis C infection after donating plasma abroad.
  • The mode of transmission was linked to the plasmapheresis donation process.

Findings:

  • Plasmapheresis donation can be an overlooked route for Hepatitis C transmission.
  • Contaminated equipment during plasmapheresis poses a risk to donors and recipients.

Implications:

  • This study suggests an unusual and underrecognized transmission pathway for HCV.
  • Enhanced screening and safety measures are needed in plasmapheresis donation to prevent HCV spread.

More Related Videos

A Cell Culture Model for Producing High Titer Hepatitis E Virus Stocks10:28

A Cell Culture Model for Producing High Titer Hepatitis E Virus Stocks

Published on: June 26, 2020

A Competent Hepatocyte Model Examining Hepatitis B Virus Entry through Sodium Taurocholate Cotransporting Polypeptide as a Therapeutic Target11:34

A Competent Hepatocyte Model Examining Hepatitis B Virus Entry through Sodium Taurocholate Cotransporting Polypeptide as a Therapeutic Target

Published on: May 10, 2022

Related Concept Videos

Transmission-based Precautions II: Airborne and Protective Environment01:25

Transmission-based Precautions II: Airborne and Protective Environment

Transmission-based precautions are for patients infected or suspected to be infected (or colonized) with organisms posing a significant risk to others. The transmission precautions include airborne and protective environment precautions.
Airborne precautions:
Use airborne precautions when treating patients known or suspected to have diseases that spread through the air—for example, tuberculosis or measles. These organisms are present in smaller droplets expelled by an infected person and...
Hepatitis01:25

Hepatitis

Hepatitis is an inflammatory condition of the liver most commonly caused by hepatotropic viruses (A–E), though non-infectious causes such as alcohol and drugs also exist.Hepatitis AHepatitis A virus (HAV) is a non-enveloped RNA virus of the Picornaviridae family. It is primarily transmitted via the fecal-oral route, typically through ingestion of contaminated food or water. After ingestion, HAV enters the bloodstream through the oropharynx or intestinal epithelium and reaches the liver. The...
Viral Hepatitis I: Introduction01:28

Viral Hepatitis I: Introduction

Viral hepatitis is an inflammatory condition of the liver caused by infection with hepatotropic viruses, most commonly hepatitis A, B, C, D, and E. Despite variations in structure and transmission, all viruses mentioned infect hepatocytes and provoke immune responses that can hinder liver function. Additionally, some non-hepatotropic viruses can also lead to hepatic inflammation.Hepatitis A VirusHepatitis A virus (HAV) is transmitted through the fecal–oral route, typically by ingestion of food...